Expression and surface assembly of antigen receptors occur during the differentiation of lymphoid progenitors into mature B and T lymphocytes, endowing each lymphocyte with a unique antigen recognition capacity. The specific polymorphic antigen binding structure on B lymphocytes is surface Ig, while the CD3Ti TCR subserves that purpose on T cells (1-3). The latter is a heterodimeric structure noncovalently associated with monomorphic CD3 subunits ('Y, S, E, and~), which assemble on the surface of T cells and interact with foreign antigens in association with MHC molecules.
Expression and surface assembly of antigen receptors occur during the differentiation of lymphoid progenitors into mature B and T lymphocytes, endowing each lymphocyte with a unique antigen recognition capacity. The specific polymorphic antigen binding structure on B lymphocytes is surface Ig, while the CD3Ti TCR subserves that purpose on T cells (1) (2) (3) . The latter is a heterodimeric structure noncovalently associated with monomorphic CD3 subunits ('Y, S, E, and~), which assemble on the surface of T cells and interact with foreign antigens in association with MHC molecules.
From prior studies it has been shown that the assembly of Ig genes takes place early in B cell development (4) in an ordered fashion, culminating in the rearrangement and expression of H chain genes (5) , and subsequently, L chain genes (6) (7) (8) , so that a functional Ig molecule is produced. The molecular architecture of the Ig H chain (IgH) and L chain (IgL) loci has been intensively studied (9) . Transfection analysis of both IgH and IgL genes revealed an element in addition to the VH or V promoters that contributed to the expression of these genes. The latter has been generally referred to as an enhancer, which was shown to possess similar properties to the well-described viral enhancer elements (10) . This element was shown to be located in the major intron between the J region and the Cp or Ck genes (11) (12) (13) (14) (15) .
More recently, the TCR loci have been characterized, and the genes encoding the Ti antigen/MHC binding subunits present on the majority (95%) of peripheral T lymphocytes (a and 0), as well as those encoding surface receptors (,y and 6) on a minor population (5 %), have been cloned . One major conclusion from those studies is that the organization of IgH and TCR genes that are composed of multiple V D, J, and C segments (except TCR-a) is very similar in both mouse and human (16, 17) . To define elements that confer a strict tissue specificity to the expression of the /3 subunit of the TCR, we have begun an analysis of a TCR V region gene promoter. This analysis will aid in the understanding of the molecular basis for T lineage differentiation and serve as a first step in identifying nuclear factors that bind to the DNA elements that we have characterized.
In this report we show that the promoter ofa functionally rearrangement Va gene at +17, while the BT prefix indicates a 3' boundary at -45, unless designated otherwise (Table  I and Fig. 5 ). Transfection Analysis. Lymphoid cells were transfected with plasmid DNA by a modification of Fujita et al. (27) . Briefly, suspension cells (Jurkat, JY, J558) were adjusted to a concentration of 3 x 105 with fresh medium for 12-16 h before transfection . 1 .5 x 10' cells were pelletted, then washed with 1 x transfection buffer (27) , and resuspended in transfection buffer and DEAE-dextran (J77, 500 ug/ml ;JY and J558, 300 Ftg/ml) with DNA (20 l~g/ml) in 1 ml. The concentration of DEAE-Dextran that gave the most efficient conversion of '4C-chloramphenicol (see below) was used in each case. In the case ofJ77 and J558, after a period of 90 min at 37°C (resuspension every 30 min), 0.1 ml DMSO was added and the cells were further incubated at room temperature (RT) for 3 min. The cells were then diluted in 10 ml of 1 x transfection buffer, pelleted at 1,200 rpm, and further washed with RPMI 1640 without serum. The washed and pelleted cells were then resuspended in 10 ml of complete medium, and incubated for -40 h at 37°C.
A slightly modified method of DEAE-dextran-mediated transfection was used for EL-4 cells . Since the subline ofcells we used attached to plastic (tissue culture 100 x 20-mm plates, Falcon Labware, Oxnard, CA), the transfection took place directly on the plates . 12-16 h before the transfection, cells were detached from large flasks by a 5' treatment with PBS-EDTA (0.6 mM, pH 8.0) at 37°C, and ti3 x 106 cells were plated on the 100 x 20-mm dish in fresh medium. The medium was aspirated, and the plates washed with transfection buffer, then 2.5 ml of a solution of 100 wg/ml DEAE-dextran and 8 hg/ml plasmid DNA in transfection buffer was applied for 30-60 min. The plates were subsequently washed with 10 ml of transfection buffer followed by serum-free RPMI 1640. The cells were incubated for 2 d in 10 ml of fresh complete medium.
Transfection of fibroblasts using CaP04, (L, Hela, Cos) was done according to established methods using 5 l~g of DNA per 100-mm dish containing 7.5 x 105 cells (28) .
Chloramphenicol Acetyl-transferase (CAT) Assay. Cells were harvested by centrifugation (suspension) or by previous treatment with PBS-EDTA (adherent), then washed two times in PBS . Freeze-thaw lysis in 0.25 M Tris HCL, pH 7 .4, and subsequent assays were done according to Gorman et al. (29) using "C-chloramphenicol (0.2 ACi at 40-60 Ci/mol; New England Nuclear, Boston, MA)) and 0.8 mM acetyl-coenzyme A (Sigma Chemical Co., St. Louis, MO) . The time of assay varied depending on the cell line (Jurkat, EL-4, and J558, 6 h; JY, Hela, and Cos, 1-2 h). A 10-min incubation of certain extracts at 60°C inactivated an activity (presumably a de-acetylase), which enhanced the conversion of chloramphenicol to its acetylated forms. This effect was proportional to the activity before inactivation, and therefore, did not change the relative activities ofthe test plasmids . Every experimental plasmid was tested in duplicate in three or more separate transfections with each cell line. The various forms of acetylated chloramphenicol were quantitated by excising the radioactive spots and scintillation counting in Betafluour (New England Nuclear). S1 and RNAse Protection. Sl probes (shown in Fig. 2 A) , and subsequent hybridization and protection methods were done according to Diamond and Goodman (30) . Maxam-Gilbert sequencing of the end-labeled probe was done according to Maniatis et al. (31) . Products ofthe S1 and sequencing reactions were subjected to electrophoresis on 8% polyacrylamide/8 M urea gels. The gels were autoradiographed at -70°C with Cronex Lightning Plus intensifying screens (DuPont Co., Wilmington, DE) .
For RNAse protection, an Nco I fragment (600 bp) encompassing the Y,e83 promoter proximal sequences from pVsf (see Table I ) was subcloned at the Sma HI site by blunt-end ligation into ptz19R (United States Biochemical Corp., Cleveland, OH) in both orientations . The plasmid ptzV0 was linearized with Eco RI, and after purification was resuspended in 10 mM Tris and 1 mM EDTA, pH 8.0 (TE), at 1 mg/ml . Labeled ssRNA transcripts were prepared as described (32) , and hybridization protection was carried out according to Melton et al. (33) . The reaction products were subjected to electrophoresis on an 8% polyacrylamide/ 8 M urea gel along size end-labeled pUC 12 Hpa II-digested size markers .
Miscellaneous Techniques. Plasmids were purified two times over CsCl ethidium-bromide gradients, and in every case the structure of the plasmid was verified by extensive restriction enzyme digestion . In many cases the boundaries of the newly inserted fragment were se-quenced to verify orientation and the identity of the insert . The 855 by of the 5' end and flanking sequences of the V68.1 gene were sequenced on both strands by the Sanger method of dideoxynucleotide termination sequencing.
Protein concentration was measured using the Bio-Rad protein assay reagent (Bio-Rad Laboratories, Richmond, CA) . Each sample in a particular assay contained the identical amount of protein, although between experiments the amount of protein varied .
Results
Sequence Analysis ofa V,88.1 Promoter. The sequence of the V,88.1 promoter is shown in Fig. 1 A, where several important sequence motifs are underlined . Examination of the proximal sequence (with respect to mRNA start site) reveals two potential transcription factor binding sites, the CCAAT box (34, 35) at -149 and a presumptive AP-1 binding site (-69 to -53; reference 36). Within the latter lies a decanucleotide (AGTGA TCA) of unknown function found in 13 of 14 Vg promoters examined (37) .
However, detailed comparisons of the upstream sequence (+1 to -800) of the V,88.1 promoter with other TCR V and VO promoters failed to show any striking sequence similarities (use of the local program; reference 38). This is not surprising, since a comparisonn of Ig V promoters (39) revealed only a striking similarity at the position of the octamer and TATA motif (40, 41) . Given that the assay is accurate to within ±1 by and adenosine is a favored base for eukaryotic transcription initiation (41), we have placed the start at the A (+1) as shown. We confirmed this finding by using the technique of RNase protection of a 32p complementary RNA probe and the same RNA samples as in Fig. 2 B (Fig . 2 C, lanes 8-11) . Note, as expected, use of a sense ssRNA probe failed to yield a protected fragment (Figure 2 C, lanes 3-6) .
The 0. 8-kb V,88.1 Promoter Fragment Is Sufficientfor T Cell Expression . To characterize the V,88.1 promoter further we used the properties of the heterologous reporter gene (CAT) to analyze expression in a variety of cultured cells . We subcloned 820 by of the 5' flanking sequence between the Xba I site at +20 and the Bgl 11 site at -800 into the pOCAT vector (24) upstream of the CAT coding sequence (Fig . 3 A) . These Restriction map of the rearranged V,88.1 segment subcloned from phage DNA. pVgJ 3 is described in Table I . The abbreviations for the restriction endonucleases are as follows: Bg1, Bgl II ; H, Hinc II ; N, Nco I; Ni, Nsi I; R, Rsa I; S, Sma I; X, Xba I; Xm, Xmn I. The boxes that contain letters represent the leader exon (L), first intron (I), variable segment (V), diversity segment (D), andjoining segment (J), which comprise a mature Vß gene segment. These sequence data have been submitted to the EMBL/GenBank Data Libraries under the accession number Y00797 . 9) , and yeast RNA (lanes 3 and 8) using an ssRNA probe that was generated from the sense (lanes 1-5) or antisense (lanes 6-11) strand from the plasmid ptzVg0 or its reverse ptzVg0' (Table I) . Shown in lanes 1 and 12 are end-labeled and Hpa 11-digested pUC 12 DNA molecular weight markers. (A) Expression vectors used in the analysis of the V68.1 promoter. Prost and Moore (24) have described pUC 12 derivatives that can accept either proximal promoter fragments (pOCAT1) or distal promoter fragments using the TK promoter proximal signals (pUTKATI). The TK mRNA 3' untranslated region was fused to the CAT gene to provide a eukaryotic polyadenylation signal sequence. (B) Results of transfection of several V,68 .1 promoter plasmids into EL-4 cells. As described in Materials and Methods, a CAT assay was performed for 6 h, and the products that were separated on TLC plates were analyzed by scintilation counting andquantitated as shown in Fig. 5 A . Plasmids transfected are the full-length promoter fragment, BP800 (lanes 1 and 2), ABP800 (lanes 3 and 4), BP045 (lanes 5 and 6), pUTKAT (lanes 7 and 8), RBP800 (lanes 9 and 10), and ARBP800 (lanes 11 and 12).
plasmids were transfected using DEAE-dextran (see Materials and Methods) into EL-4 (a murine T cell tumor) and Jurkat (human T cell tumor; data not shown) cells. As shown in Fig. 3 B (lanes 1 and 2 vs. 7 and 8) it is clear that the BP800 plasmid stimulates greater CAT activity in T cells than pUTKAT, which contains the TK promoter.
To further define the sequences necessary for T cell-specific Va promoter activity, a series of 5'-3' deletions were constructed and assayed in both Jurkat and EL-4 cells.2 A schematic illustrating the structure of these deletions as well as the others presented in this report are shown in Fig. 4 , A and B. This deletion series demonstrates that the majority of the promoter activity resides upstream of -350, predominantly between -800 and -510 (Fig. 4 A) . In fact, an internal deletion of sequences between -510 and -45, which leaves the upstream sequences intact, results in a plasmid with T cell Va promoter activity equivalent to the intact promoter plasmid BP800 (Fig. 4 A) .
Deletion of Transcriptional Start Site and Upstream GATA Sequence Abrogates Transcription from the V,68.1 Promoter . To determine whether the CAT protein acetylating activity resulted from mRNA that was initiated in plasmid BP800 using the endogenous z We have subsequently found the murine line to be more active for Vs8 promoter-stimulated CAT activity than most human cell lines (JM, REX, HBPALL ; data not shown), so that the effect of deletions that reduce the strength of the promoter are more easily seen in EL-4 than in Jurkat cells. However, the relative effects of the deletions are identical between EL-4 andJurkat, as presented in the data on Jurkat transfections shown in tabular form. Table I. start site (determined above), we excised the proximal promoter sequences using the combination of Nsi I and Xba I digestion ( Fig . 1 B and Table I ) . This deletion plasmid (OBP800) was transfected into Jurkat and EL-4 cells along with another deletion plasmid (ORBP800) similarly prepared, which contains the RSV enhancer ( Fig. 3 B and Table I ) . Note that essentially no CAT activity arises from these plasmids, as compared with the undeleted plasmids shown in Fig. 3 B (lanes 3 and 4, 11 and 12 vs . 1 and 2, 9 and 10). A deletion from -800 to -45 did not completely abolish IgHETK digested with Hinc II to remove TK promoter, the Bgl II-Xba I fragment from pV;/3 was blunt ended, and ligated into the Hinc II site . RBP800
PROMOTER OF V0 GENE ACTS IN
The Xba I-Bgl II fragment was ligated to Xba I-digested pOCAT . The 309-bp Bam HI fragment from pRTK was ligated to the Bgl II end of the promoter fragment, Barn HI cut back of multiple inserts and digestion of polylinker, was followed by isolation of the linear plasmid over agarose, and subsequent ligation gave the expected product . BP570 pVg l6 digested with Nco I and Xba I, the 587-bp fragment was blunt ended with Klenow and cloned into pUTKAT. BP510 BP800 was partially digested with Xmn I and completely with Sac I, the ends were made blunt with Klenow, and the plasmid was closed by ligation . BP450 BP800 was digested with Hinc II, and the 467-bp fragment was subcloned into pOCAT at the Hinc 11 site .
BP350
The Bgl II-Xba I fragment from pVg O was digested with Rsa I, and cloned into pOCAT, which was partially digested with Sma HI and completely with Xba I . BP045 BP800 was digested with Sac I and Nsi I to remove the internal 755-bp fragment, and the plasmid was closed by ligation . ABP800 BP800 or RBP800 was digested with Xba I and Nsi I to remove a 72-bp fragment, made ORBP800 blunt with Klenow, and closed by ligation . BP8045 BP800 was digested with Nsi I and partially with Hinc II to remove a 405-bp fragment, the ends were blunted, and the plasmid closed by ligation . BP8051 BP800 was digested completely with Nsi I and partially with Xmn I to remove an internal 455-bp fragment, the ends were blunted, and the plasmid closed by ligation . BT800
Isolate the Nsi I-Bgl II fragment from pV,,O, blunt end, and ligate to Xba I-digested and BT'800 blunt-ended pUTKAT .
BT570
Isolate the Nco I-Nsi I fragment of PB800, and ligate it to Xba I-digested and blunt-ended pUTKAT .
BT445
Isolate the Hine II-Nsi I fragment from BP800, blunt end, and ligate it to Xba I-digested and blunt-ended pUTKAT .
BT8044
Isolate the Bgl II-Hinc II fragment from BP800, blunt end, ligate to blunt-ended and Xba I-digested pUTKAT .
BT8051
Isolate the Bgl II-Xmn I fragment from BP800 blunt end, and ligate to blunt-ended and Xba I-digested pUTKAT .
BT8057
Isolate the Bgl II-Nco I fragment of BP800, blunt end, and ligate to blunt-ended and BT'8057 Xba I-digested pUTKAT .
BT8057/P30
Isolate the 300-bp Rsa 1-digested fragment from pUC12, ligate it to Sal I-digested and bluntended BT8057 .
BT8063
Isolate the Bgl II-Ssp I fragment of BP800, blunt end, and ligate to Xba I-digested and blunt-ended pUTKAT .
CAT activity (Fig. 3 B, lanes 5 and 6) as compared with the ABP800 plasmid (Fig .  3 B, lanes 3 and 4) . Collectively, these results suggest that the initiation site we experimentally determined (Fig. 2 B) is correct, and presumably utilized in the plasmids described here. V,68 .1TK Promoter Fusion Plasmids Are Active in T Cells. The identification of a discrete region containing T cell promoter activity lead us to construct a series ofplasmids using the upstream region of the V,e8 .1 promoter beyond -5 fused to the TK promoter in the plasmid pUTKAT (Table I and Figure 4 B ). These plasmids were transfected into bothJurkat and the EL-4 cell line (Fig. 4 B) . A surprising result occurred when we examined the results of transfection analysis of plasmids containing sequences between -800 and -570 fused in either orientation to the TK promoter in pUTKAT as shown in Fig. 5 , lanes 1-4, and summarized in Fig. 4 B. There is little difference in the CAT activities generated by plasmids with the 230-bp 5' flanking sequence in either orientation, although the stimulation above pUTKAT is 10-fold when the V08 promoter upstream fragment is in the natural orientation (Fig. 5 , lanes 1 and 2 vs. 7 and 8). The addition ofa 300-bp Rsa 1 fragment from pUC 12 between the TK promoter and the V,B8.1 promoter 5' flanking sequence only slightly decreases its ability to stimulate CAT activity (Fig. 5, lanes 5 and 6) . Further truncation (fragment -800 to -635 ; Fig. 4 B) reduces the CAT activity, suggesting that we have entered an important segment of the 230-bp fragment . Since we have not made additional 3' deletions of the Vp promoter fragment, the precise 5' boundary of the upstream element is still unknown. These results provide evidence for a T cell promoter element (TPE) contained within the 230-bp upstream sequence of the Va8 promoter.
It is striking that the precise deletion of 60 by between -450 and -510 (compare BP8045 vs. BP8051 or BT8044 vs. BT8051 in Fig. 4) activates the proximal sequences of either TK or the V08 promoter. The molecular basis for the negative activity of this sequence is not understood, although its activity is equivalent within the context of the V08 or TK promoter proximal DNA (Fig . 4) . A further point is that the interaction of the -45 to -800 fragment with its natural proximal sequence (V08) is more efficient than when it is apposed to the TK promoter (Fig. 4, A and B) . Presumably, certain sequence-specific alignments of DNA elements are more produc- Table   II ) using CaP04 (27) . The results demonstrate that plasmids that contain either proximal or upstream VF8.1 promoter elements such as BP800 (Fig . 6 , lanes 7 and 8) or BP8051 (Table II) are inactive with respect to TPE activity in fibroblasts .
At the same time, we tested a series of V,88.1TK promoter fusion plasmids in fibroblasts using CaP04 transfection . If we compare in each case the activity of a fusion plasmid containing upstream V,88 .1 promoter flanking DNA to the parental TK promoter plasmid, it is clear that in fibroblasts, no increase in CAT activity can be detected (Fig. 6 , lanes 3-6 vs . 9-10 and Table II ) . The small amount of CAT activity observed with BP plasmids may be attributed to the presence of basal transcriptional elements such as a putative CAAT box, AP-1 recognition site, and the universal TATA element (see Fig . 1 A) . Experiments with the IL-2 promoter using this vector system reveal a similar basal CAT activity in all cells tested (data not shown) . Note, by way of contrast, the large stimulation of cat activity by the pRTK plasmid (Fig. 6, lanes 1 and 2) . Transfection in Lymphoid Cells Other Than T Cells . To more precisely define the tissue specificity of the V88.1 promoter and determine whether it functions in cells of the B lineage, two different B cell lines JY and J558, which are, respectively, a human EBVtransformed mature B cell and a murine B cell myeloma were examined . The full-length V,88.1 promoter (BP800 ; Fig. 7, lanes 3 and 4) , the deleted version, which still contains the TPE (BP8051; Fig. 7, lanes 5 and 6) , and the TPE alone fused to TK (BT8057; Figure 7 , lanes 7 and 8) were separately transfected into both murine and human B cell lines. The results are unequivocal; in both non-T cell lines the V,68.1 promoter proximal elements are inactive (Fig. 7 and Table II) . Furthermore, in contrast to the situation in T cells, the 230-bp TPE fragment does not further stimulate TK promoter activity in B cells. Note that we have included the RTK plasmid (Fig . 7 , lanes 9 and 10) in this experiment, which is several-fold more active than the TK plasmid (Fig . 7, lanes 1 and 2) alone, thus indicating that it is possible to activate the TK promoter in these cell lines (see also Table 1I ).
We conclude that the V,68.1 promoter contains sequences upstream of the start site of transcription that impart a T lineage lymphoid-specific promoter selectivity. The magnitude ofthe selectivity in murine lymphoid cells is 30-50-fold, and 20-30-fold in human cells (Fig . 4 and Table f1 ). This would seem to be enough to account V,Q8.1 promoter plasmids are inactive in either murine or human B cells. Transfections and CAT assays were carried out as described in Materials and Methods and the legend to Fig. 3 B. J558 (A) , a murine B cell line, or JY (B), a human EBVtransformed B cell line were transfected with plasmids pUTKAT (lanes 1 and 2) , BP800 (lanes 3 and 4), BP8051 (lanes 5 and 6), BT8057 (lanes 7 and 8), and pRTK (lanes 9 and 10). Quantitation of the results by scintillation counting are shown in Table II . TABLE III Quantitative Analysis of CAT Assay Results from Transfected Vp8.1 Promoter Plasmids: Effect of RSV and IgH Enhancers in B and T Cells
The numbers shown are the percentages of acetylated CAM determined after scintillation counting of the cut-out spots from TLC plates . Each point is the average of two separate determinations that varied t 5 To . For comparison, data on the percentage acetylation with BP800 (EL-4, 12% ;J558, 0 .1 To Jurkat, 13% ; and JY, 1 .3%) and pUTKAT (EL-4, 2 .4% ; J558, 2 .5% ; Jurkat, 5 .2% ; and JY, 13%) in the cell lines tested are presented here . The reaction of CAM to its acetylated form in this instance is nonlinear because of the strength of the interaction between the enhancer and the promoter, thus underestimating the difference between EL-4 and J558 . 1 Nonlinear acetylation reaction .
for the T cell specificity of the rerranged endogenous V,B8.1 gene as determined by Northern blot analysis of TCR-specific mRNA (16, 17) .
IgH Chain Enhancer Does'not Stimulate V,68.1 Expression in B Cells. The striking result that demonstrated a T vs . B selectivity of the V,B8.1 promoter could be further tested by taking advantage of the transcriptional enhancer elements that are active in either lymphoid cells exclusively (H chain enhancer, IgHE ; references 12, 13, and 43) or throughout all eukaryotic cells such as the RSV enhancer. To this end, either the 1.0-kb murine IgHE-containing fragment (12) or the previously described RSV enhancer (25) was placed 5' of both the TK and V,B8.1 gene promoters (see Table  I ), and they were separately transfected in duplicate into both murine and human B and T cells along with several other previously described plasmids . As shown in Table III , the IgHE is very active in stimulating expression from the TK promoter in all the cell lines tested, especially J558 . The RSV enhancer is most active in human cell lines, but substantial activity occurs in both murine cell lines tested (Table III) . A different story emerges when we examine the results of transfection into lymphoid cells of V,88.1 promoter plasmids containing the RSV or IgHE enhancer elements upstream of -800 (Table III) . The V,e8.1 promoter is activated in T cells by both of these elements, however, the results in B cells indicate a very feeble interaction . These results are in sharp contrast to the experiments with TK promoter (Table  III) , indicating that a TCR promoter is resistant to activation by these enhancers in B cells. (48) Ti a, we considered it particularly important to undertake the present analysis . Our study of the V,68 .1 promoter has demonstrated both the presence of an autonomous element referred to as TPE (Fig . 5) , and the tissue-specificity of the whole 0.80-kb fragment containing the promoter sequences (Figs. 4 B , and 6 and 7) .
As a result of previous studies with TCR and MHC genes that localized expression elements within intronic sequences (see above), we first concentrated on defining regulatory sequences downstream of the promoter within the intron between the rearranged J of the V,e8.1 V gene and C,61 (see reference 49 for a map of this region). However, transfection analysis of plasmids containing the -4 .0 kb of the intron cloned in pUTKAT revealed no T cell-specific stimulation of the TK promoter (data not shown) in Jurkat or EL-4 cells. Instead, we found that a 0.80-kb promoter-containing fragment was active both in human and murine T cells (Fig . 4) .
Sequence analysis of the V,38.1 promoter fragment revealed similarities only to basal transcription elements (see Results), but no tissue-specific elements (TCR V« and VR promoters, Ig V and V promoters, IL-2 promoter, MHC class I and class II promoters, and IgH enhancer including the octamer) from a diverse set of genes was located in this region . However, comparison of the sequences of the recently described COE and the V,B8.1 promoter showed significant similarities, even though it was a human/mouse comparison (see Results and reference 21). However, a counterpart to the murine Y CO enhancer has not yet been identified in human. Nevertheless, a combination of expression elements that serve to enhance transcription is found both in the IgH (23, 50) and IgL (14, 51) loci of the mouse or the globin (52, 53) and H5 histone (54) loci in the chicken, which gives added significance to the similarities that were found in the sequence comparison of the V,a8.1 promoters 5' flanking DNA with the murine COE (see Results) .
To prove that the TPE is separate from and independent of the V,B8 .1 proximal sequences, we subcloned DNA upstream of -45 5' to the TK promoter in pUTKAT, for example, as shown by BT8051 . In this series of experiments we demonstrated that the TPE could confer upon the TK promoter T cell-specific expression, and that as little as 230 by was required . Interestingly, DNA between -445 and -510 seemed to act to repress the TPE (Fig. 4 B) . This small DNA element is also capable of repressing the TPE when the V,Q8.1 promoter proximal signals are used (i .e ., BP8045 vs . BP8051 ; Fig. 4 A) . Such "negative" activity has been observed in the promoters of MHC class I genes (55), (3 (42) , and the IgH enhancer (57) . The molecular basis for the negative influence of this sequence remains to be determined .
The sequence shown, by Anderson et al . (AGTGAT/CG/ATCA) (37) , to be common to many murine VR promoters as well as V,a8.1 (earlier pointed out by Siu et al . [20] , for V,08 promoters as part of a larger 16-bp region of similarity) is not obligatory for the function of the TPE described herein . In fact, the plasmids BP350 or BP045 are very similar in their expression properties in T cells, even though BP350 contains the decanucleotide whereas BP045 does not. Earlier studies of this region using the DNAse I footprint technique (49) localized a segment of 23 by protected by extracts from lymphoid and nonlymphoid cells. Based on the nucleotide sequence, a candidate for the protein responsible for this observed protection is the transcription factor AP-1, which is found in most eukaryotic cells (see Results and Fig. 1 A) . Thus, the T cell lineage specificity of this interaction remains to be determined .
Using the above transient transfection methods we also made a series of observations concerning the fine specificity of V,e8.1 expression in lymphoid cells. We found that none of the plasmids driven by the V#8.1 promoter or TPETK constructs that were preferentially expressed in T cells were active in B cells (Fig . 7) . More importantly, using either a lymphoid-specific enhancer active in B and T cells (50) or a ubiquitous functional enhancer (RSV), we were unable to activate the V88.1 promoter in B cells (although activation occurred in T cells; Table III ) . In a similar study of V, promoter specificity (50), it was found that enhancer-activated expression of a V, promoter does not occur in fibroblasts or EL-4 cells. Similarly, the regulated T cell-specific IL-2 promoter could not be activated by an enhancer in non-T cells (26, 58) .
The possible implications of these results for transcriptional specificity and the control of rearrangement of receptor genes in B and T cells should be considered . Several types of evidence have accumulated that demonstrate that V, genes (59), which are either unrearranged or specifically rearranged, are restricted in expression to B cells. To date, only transcripts arising from non-V start sites within the IgH locus have been found in T cells (60) (61) (62) . 3 Circumstantial evidence from chromatin accessibility studies (66, 67) highlights the role of DNAse I-accessible chromatin as a factor in the process of gene rearrangement. These arguments have been formalized by Alt and his colleagues (4, (68) (69) (70) by a careful analysis of an artificial recombination substrate in B and T cells. They have found that increased transcription is associated with substrate rearrangement, and significantly that TCR V region gene segments (Dg and J/3) can recombine appropriately in B cells. Furthermore, a Vp-DOJa-IgH enhancer recombination substrate undergoes Do to Ja rearrangements in both B and T cells, but only undergoes Va to DJO rearrangements in T cells. These findings demonstrated that the IgH enhancer was sufficient for Dojo rearrangements but that elements associated with the VS (possibly the promoter) controlled tissue-specific V3 to DJO rearrangement (L . Ferrier and F. W. Alt, personal communication) .
Given the correlation between transcription and rearrangement, our data suggest that the reason for the inactivity of the substrate in B cells is the lack of transcriptional activity from the Va promoter (see Fig. 7, A and B) . Experiments in cultured B and T cells with recombination substrates utilizing the V,B8.1 promoter could directly test the hypothesis that rearrangement is dependent upon transcription of the utilized V gene . More important would be to determine whether the activity of the TPE in conjunction with downstream transcriptional start signals would be s An example exists in the literature (63-65) of a V gene transcribed in a T cell tumor after rearrangement caused it to fuse with part of the J~Ca locus on chromosome 14. In this case, expression elements from the newly juxtaposed locus may have overridden the normal control elements 5' of the V, promoter in these morphologically transformed human T cell tumors. adequate to activate rearrangement within a recombination substrate. Finally, experiments using cell fusions of B and T cells followed by assay of either the endogenous or introduced V0 promoters for expression would help determine whether there exists an inhibitory substance in B cells that extinguishes expression of specific TCR promoters .
Summary
We have characterized the sequence contribution of DNA 5' of a functionally rearranged TCR promoter (V,88.1) on its T lineage-specific expression through the use of the chloramphenicol acetyl-transferase (CAT) reporter gene . A 230-bp fragment located 570 by upstream of the determined transcription start site of the V,68.1 promoter confers a T lineage specificity of expression to a heterologous promoter. The inability of the V,68.1 promoter and its associated elements to function in B cells suggests the existence of a mechanism to prevent inappropriate VS gene expression in B cells. Of considerable interest is the fact that both a B cell-specific and a nontissuespecific enhancer element were incapable of stimulating significant expression of this promoter in B cells. We discuss the implication of these results on the process of rearrangement of both Ig and TCR genes, and the differentiation of the lymphoid system .
